Navigation Links
FASEB SRC announces conference registration open for: Hematologic Malignancies
Date:2/4/2013

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) announces the opening of registration for the Science Research Conference (SRC): Hematologic Malignancies.

The 2013 FASEB conference on Hematologic Malignancies is an important and unique scientific conference where basic and translational research on leukemias, lymphomas, and myeloma is presented in detail in the premier meeting in the field. The underlying theme for the 2013 conference is "Genomics and Targeted Therapy". This meeting includes outstanding researchers from around the world presenting cutting edge research directed towards genomic profiling of hematologic malignancies, mechanistic studies into hematopoietic transformation, and the development of novel, molecularly targeted therapies for patients with hematologic neoplasms.

FASEB SRC has announced a total of 34 SRCs in 2013. To register for an SRC, view preliminary programs, or find a listing of all our 2013 SRCs, please visit www.faseb.org/SRC.


'/>"/>

Contact: Robin Crawford, CMP
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB SRC announces conference registration open for: Mechanisms in Plant Development Conference
2. FASEB SRC announces conference registration open for: Ciliate Molecular Biology
3. FASEB SRC announces conference: Renal Hemodynamics: Integrating with the Nephron & Beyond
4. FASEB SRC announces: Mechanism and Regulation of Prokaryotic Transcription Conference
5. FASEB SRC announces conference registration open: The Biology of Calpains in Health and Disease
6. FASEB SRC announces conference: Gastrointestinal Tract XV: Epithelia, Microbes, Inflammation & Cancer
7. FASEB urges biomedical research community to speak out against sequestration
8. FASEB lauds Air India for transporting research animals
9. Undergraduate Student Summer Research Award recipients announced for the 2012 FASEB MARC summer research opportunity program
10. FASEB 2013 Excellence in Science Award recipient announced
11. Elsevier announces the launch of a new journal: Anthropocene
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... India , March 23, 2017 The report "Gesture ... Touchless Biometric), Industry, and Geography - Global Forecast to 2022", published by MarketsandMarkets, ... at a CAGR of 29.63% between 2017 and 2022. ... ... ...
(Date:3/22/2017)... 21, 2017   Neurotechnology , a provider ... today announced the release of the SentiVeillance ... improved facial recognition using up to 10 surveillance, ... computer. The new version uses deep neural-network-based facial ... it utilizes a Graphing Processing Unit (GPU) for ...
(Date:3/22/2017)... -- Vigilant Solutions , a vehicle location and ... today the appointment of retired FBI special agent ... development. Mr. Sheridan brings more than 21 ... on the aviation transportation sector, to his new role ... served as the Aviation Liaison Agent Coordinator (ALAC) in ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... Mass. , March 23, 2017 /PRNewswire/ ... partner to global in vitro diagnostics manufacturers ... of the industry,s first multiplexed Inherited ... disease testing by next-generation sequencing (NGS). The ... were developed with input from industry experts ...
(Date:3/23/2017)... , March 23, 2017 NetworkNewsWire ... ... death, putting significant strain on health care systems, in terms ... diagnoses rises, so too does the development of innovative and ... side effects. Among the many types of cancer treatments, a ...
(Date:3/22/2017)... TARRYTOWN, N.Y. , March 22, 2017 Regeneron ... among the Regeneron Genetics Center (RGC), U.K. Biobank and GSK ... in the U.K. Biobank resource. The initiative will enable researchers ... of new medicines for a wide range of serious and ... ...
(Date:3/22/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... ), a clinical-stage pharmaceutical company focused on the ... that Dr. Miriam Kidron , Oramed,s Chief ... Insulin for Diabetes Treatment: Bypassing the Roadblock," at ... Therapeutics (OPT) Boston Conference in Cambridge, Massachusetts ...
Breaking Biology Technology: